Photo: Almirall

Photo: Almirall

Last modified: 19/09/2012

The Almirall Group opens a subsidiary in Canada

The pharmaceutical company is continuing its internationalisation process in North America. Currently it is present in 70 countries and has 13 offices worldwide.

Almirall advances in its internationalisation process. The Chief Executive Officer of the pharmaceutical company, Eduardo Sanchiz, has announced the forthcoming opening of a regional office in Toronto (Canada), the 8th largest drug market in the world.

From this new branch, the first in North America, the company will distribute drugs such as aclidinium, recently approved in Europe and the United States, and other innovative medicines for medical areas such as respiration and dermatology.

Currently the Almirall group is present in 70 countries and has 13 subsidiaries worldwide. Among the challenges facing the company, which had a turnover of 374 million euros during the first half of 2012, is its expansion into Asia and Latin America.


Browse all news

Read the last newsletters

Get informed

Subscribe to the Barcelona Business newsletter if you want to receive information on the current state of the economy in Barcelona.